Understanding Health Worker and Community Antibiotic Prescription-Adherence Practices for Acute Febrile Illness: A Nested Qualitative Study in the Shai-Osudoku District of Ghana and the Development of a Training-and-Communication Intervention.
acute febrile illness
antibiotics resistance
prescription adherence communication
prescription-adherence behavior
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
25 07 2023
25 07 2023
Historique:
received:
13
02
2023
medline:
27
7
2023
pubmed:
25
7
2023
entrez:
25
7
2023
Statut:
ppublish
Résumé
The aim was to explore behavioral factors relating to the prescription and communication of prescription-adherence messages for patients with acute febrile illness, from which to develop a training-and-communication (T&C) intervention to be delivered as part of a clinical trial. The study undertook a content analysis of primary, qualitative data collection using in-depth interviews and focus group discussions, informed by the Capability, Opportunity, Motivation (COM-B) theory of behavior, the Theoretical Domains Framework (TDF), and Behavior Change Wheel (BCW) approach, in health facilities (39 health workers) and communities (66 community members) in the Shai-Osudoku District of Ghana. Health workers perceive that prescribers' and dispensers' communication with patients is influenced by the following factors: patient's educational level, existing disease conditions, health worker's workload, patient's religion, language barrier between health worker and patient, outcome of laboratory results, and medicine availability. Community members' adherence to prescription was influenced by the availability of money and affordability of medicine (outside of provision by the national health insurance scheme), the severity of the condition, work schedule, and forgetfulness. Our study contributes to knowledge on nesting qualitative methods in a clinical trial and reveals factors that affect the antibiotic prescription communication process. Tailored messages for patient-specific needs can shape antibiotic prescription adherence behavior and ultimately contribute to decreasing the incidence of antibiotic resistance.
Sections du résumé
BACKGROUND
The aim was to explore behavioral factors relating to the prescription and communication of prescription-adherence messages for patients with acute febrile illness, from which to develop a training-and-communication (T&C) intervention to be delivered as part of a clinical trial.
METHODS
The study undertook a content analysis of primary, qualitative data collection using in-depth interviews and focus group discussions, informed by the Capability, Opportunity, Motivation (COM-B) theory of behavior, the Theoretical Domains Framework (TDF), and Behavior Change Wheel (BCW) approach, in health facilities (39 health workers) and communities (66 community members) in the Shai-Osudoku District of Ghana.
RESULTS
Health workers perceive that prescribers' and dispensers' communication with patients is influenced by the following factors: patient's educational level, existing disease conditions, health worker's workload, patient's religion, language barrier between health worker and patient, outcome of laboratory results, and medicine availability. Community members' adherence to prescription was influenced by the availability of money and affordability of medicine (outside of provision by the national health insurance scheme), the severity of the condition, work schedule, and forgetfulness.
CONCLUSIONS
Our study contributes to knowledge on nesting qualitative methods in a clinical trial and reveals factors that affect the antibiotic prescription communication process. Tailored messages for patient-specific needs can shape antibiotic prescription adherence behavior and ultimately contribute to decreasing the incidence of antibiotic resistance.
Identifiants
pubmed: 37490740
pii: 7230997
doi: 10.1093/cid/ciad327
pmc: PMC10368414
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
S182-S190Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. E. Arthur reports research funding from FIND. P. H. reports research funding from FIND and an honoraria payment from Oxford International Biomedical Centre (OIBC). A. A., E. Arthur, G. O., J. W., R. B., and S. O. report research funding and donation of diagnostic kits from FIND, Global Alliance for Diagnostics. J. N. reports research funding and consulting fees from FIND, the Global Alliance for Diagnostics. O. S. reports being employed by FIND, the Global Alliance for Diagnostics, from 2019–2021. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Références
Trials. 2018 Oct 29;19(1):589
pubmed: 30373646
PLoS One. 2020 May 19;15(5):e0233345
pubmed: 32428012
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
BMC Infect Dis. 2016 May 17;16:208
pubmed: 27188538
BMC Health Serv Res. 2020 Oct 27;20(1):978
pubmed: 33109158
Afr J Emerg Med. 2017 Sep;7(3):93-99
pubmed: 30456117
Health Psychol. 2017 Apr;36(4):402-409
pubmed: 28206788
Contemp Clin Trials. 2014 Jul;38(2):338-43
pubmed: 24937019
Oman Med J. 2011 May;26(3):155-9
pubmed: 22043406
Qual Health Res. 2007 Dec;17(10):1372-80
pubmed: 18000076
BMJ Open. 2019 Nov 26;9(11):e032081
pubmed: 31772096
Ir J Med Sci. 2018 Nov;187(4):969-986
pubmed: 29532292
BMC Health Serv Res. 2017 Jun 20;17(1):422
pubmed: 28633631
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Clin Microbiol Infect. 2021 Apr;27(4):590-596
pubmed: 32505586
BMC Infect Dis. 2019 Nov 13;19(1):970
pubmed: 31722678
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Trials. 2013 Feb 21;14:54
pubmed: 23433341
Malar J. 2011 Dec 20;10:377
pubmed: 22183039